EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

BACKGROUND: There is a growing appreciation for radio-sensitiser use in multi-modal cancer treatment models. Squamous cell anal carcinoma (SCAC) is a rare gastrointestinal tumour traditionally treated with concurrent chemotherapy and radiation. Cetuximab, an epidermal growth factor receptor (EGFR) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Paliga, A, Onerheim, R, Gologan, A, Chong, G, Spatz, A, Niazi, T, Garant, A, Macheto, D, Alcindor, T, Vuong, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504953/
https://www.ncbi.nlm.nih.gov/pubmed/23093229
http://dx.doi.org/10.1038/bjc.2012.479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504953/
https://www.ncbi.nlm.nih.gov/pubmed/23093229
http://dx.doi.org/10.1038/bjc.2012.479

Ejemplares similares